Table 3.
Molecular classification | Neuropathological subtypeb | Mutated genesb |
FTLD-tau | Pick’s disease | MAPT |
Corticobasal degeneration | MAPT | |
Progressive supranuclear palsy | MAPT | |
Argyrophilic grain disease | MAPT | |
Neurofibrillary tangle–predominant dementia | MAPT | |
Multiple system tauopathy with dementia | MAPT | |
White matter tauopathy with globular glial inclusions | MAPT | |
FTLD–TAR DNA-binding protein 43 | Type A | GRN |
C9orf72 | ||
Type B | C9orf72 | |
Type C | ||
Type D | VCP | |
FTLD–fused in sarcoma | Atypical FTLD with ubiquitinated inclusions | FUS |
Neuronal intermediate filament inclusion disease | FUS | |
Basophilic inclusion body disease | FUS | |
FTLD–ubiquitin proteasome system | Frontotemporal dementia linked to chromosome 3 | CHMP2B |
Adapted from Reference 154.
Characteristic pattern of pathology, not the clinical syndrome.